Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Atsuhito Nakao,Mozhgan Afrakhte,Anita Morn,Takuya Nakayama,Jan L. Christian,Rainer Heuchel,Susumu Itoh,Masahiro Kawabata,Nils-Erik Heldin,Carl-Henrik Heldin,Peter ten Dijke
DOI: https://doi.org/10.1038/39369
IF: 64.8
1997-01-01
Nature
Abstract:TGF-β signals from the membrane to the nucleus through serine/threonine kinase receptors and their downstream effectors, termed SMAD proteins 1 . The activated TGF-β receptor induces phosphorylation of two such proteins, Smad2 and Smad3 ( refs 2 , 3 , 5 , 6 ), which form hetero-oligomeric complex(es) with Smad4/DPC4 ( refs 5 , 6 , 7 , 8 , 9 , 10 ) that translocate to the nucleus 2 , 4 , 5 , 7 , where they then regulate transcriptional responses 11 , 12 . However, the mechanisms by which the intracellular signals of TGF-β are switched off are unclear. Here we report the identification of Smad7, which is related to Smad6 ( ref. 13 ). Transfection of Smad7 blocks responses mediated by TGF-β in mammalian cells, and injection of Smad7 RNA into Xenopus embryos blocks activin/TGF-β signalling. Smad7 associates stably with the TGF-β receptor complex, but is not phosphorylated upon TGF-β stimulation. TGFβ-mediated phosphorylation of Smad2 and Smad3 is inhibited by Smad7, indicating that the antagonistic effect of Smad7 is exerted at this important regulatory step. TGF-β rapidly induces expression of Smad7 mRNA, suggesting that Smad7 may participate in a negative feedback loop to control TGF-β responses.